CompletedPhase 1

Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors

NCT02014337

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

ACRC/Arizona Clinical Research Center Inc.

Tucson, Arizona, United States

+10 additional locations

Save this trial

ACRC/Arizona Clinical Research Center Inc.Tucson, Arizona, United States
H. Lee Moffitt Cancer Center & Research InstituteTampa, Florida, United States
Winship Cancer Institute, Emory UniversityAtlanta, Georgia, United States
Rita Nanda, MDChicago, Illinois, United States
Quest ResearchRoyal Oaks, Michigan, United States
St. Luke's Cancer InstituteKansas City, Missouri, United States
Comprehensive Cancer Centers of NevadaLas Vegas, Nevada, United States
Texas Oncology-Baylor Charles A. Sammons Cancer CenterDallas, Texas, United States
Cancer Care Centers of South TexasSan Antonio, Texas, United States
Texas Oncology - TylerTyler, Texas, United States
Virginia Cancer SpecialistsFairfax, Virginia, United States